Skip to main content
Fig. 3 | Health and Quality of Life Outcomes

Fig. 3

From: Health state utility estimates for value assessments of novel treatments in Huntington’s disease: a systematic literature review

Fig. 3

Comparison of published utility scores for patients with HD by rater type. a. Utility Scores Measured by EQ-5D. b. Utility Scores Measured by SF-6D

HD = Huntington’s disease; EQ-5D = EuroQol 5-dimension; EQ-5D-5L = EuroQol 5-dimension 5-level; SF-6D = short-form 6-dimension; TFC = total functional capacity

Note: Error bars represent 95% confidence intervals derived from reported standard deviation and sample size (size of diamond represents the sample size). Country refers to location of residence of study participants

a Range for published mean EQ-5D and SF-6D utility for general US population of ages 35 to 64 years [49].

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us